✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Novo Nordisk A/S

Common Name
Novo Nordisk
Country
Denmark
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
67,900
Ticker
NOVO B
Exchange
Nasdaq Copenhagen
Description
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabe...

Novo Nordisk's Energy Data Preview

In 2025, Novo Nordisk disclosed key data related to its energy management practices, providing transparency into its operational energy use in line with recognized sustainability reporting frameworks.

Novo Nordisk disclosed progress toward renewable energy adoption, highlighting the share of total energy sourced from renewable versus non-renewable sources.

Metric (GJ)2025202420232022 - 2017
Total Energy Consumption
6,213,600a
5,040,000a
3,783,600a
Non-Renewable Energy Consumption
2,671,200a
1,713,600a
N/A
Renewable Energy Consumption
3,542,400a
3,326,400a
N/A
Renewable Energy Production
3,600a
0a
N/A
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Novo Nordisk’s Energy Management Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Novo Nordisk’s data sources below and access millions more through our Disclosure Search.

a. Novo Nordisk's Annual Report 2025

Insights into Novo Nordisk's Energy Renewability

In 2025, Novo Nordisk consumed a total of 6.21 million Gigajoules of energy across its operations. Of this total, 57.01% was sourced from renewable energy, either derived from natural resources like biofuels, biomass, or biogas, or generated using renewable technologies such as solar or wind power. The remaining 42.99% was classified as non-renewable energy, coming from fossil-based fuels such as coal, natural gas, or crude oil, or from non-renewable generation technologies like nuclear power.a

Novo Nordisk's Energy Renewability Rate

57%

How much of Novo Nordisk's energy consumed is renewable?

In 2025, Novo Nordisk consumed a total of 6.21 million Gigajoules of energy, of which 57.01% was derived from renewable sources, including biofuels, biomass, biogas, solar, and wind power.a

This moderate level of renewable energy adoption indicates that Novo Nordisk is transitioning toward cleaner energy sources, though a significant share of its energy mix still relies on non-renewable inputs.

Are Novo Nordisk's energy practices becoming more sustainable?

Since 2023, Novo Nordisk's total energy consumption increased by 64.22%, including a 23.29% increase in 2025, reflecting a sustained rise in overall energy demand.a

Over the same period, the share of renewable energy in Novo Nordisk's consumption decreased by 13.62%, showing a recent negative trend in clean energy adoption.a

Novo Nordisk's Renewable vs Non-renewable Energy Over Time

3.9 M1.9 M103.36 k3.9 MGigajoules (GJ)2025202457%66%43%34%
  • Renewable Energy Consumption
  • Non-Renewable Energy Consumption
Want Full Access to Novo Nordisk's Energy Dataset?
Start 30-Day Free Trial